The Impact of 24/7-phone Support on Readmission After Aortic Valve Replacement, a Randomized Clinical Trial (AVRre)

University of Oslo (UIO)

Status: Completed

Conditions: Aortic Valve Disease

Treatments: Other: 24/7-telephone support

Study type: Interventional

Funder types: Other

Identifiers

NCT02522663

AVRre

Details and patient eligibility

About

Aortic Valve Replacement (AVR) surgery for aortic valve disease continues to increase in numbers. With better surgical techniques and equipment, also older patients can be operated on, resulting in an growth of the older population. AVR is characterized by high rates of hospital readmissions, resulting in suboptimal care planning and higher health care costs. Hence, it is important to develop strategies to reduce hospital readmissions following AVR. The purpose if this study is to develop and test the efficacy of a 24/7-phone support in the reduction of readmissions after AVR treatment. Secondary outcomes are a reduced level of anxiety, less depressive symptoms and a better health related quality of life.

Enrollment: 288 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Treatment with AVR (biological or mechanical) single, AVR (b or m)+aortocoronary bypass, AVR (b or m)+supra coronary tube graft
• Can understand, speak and write native Language (norwegian), and be able to fill in the questionnaires
• Can be contacted by phone after discharge from hospital

Exclusion criteria

• Patients who have been admitted to intensive care for more than 24 hours
• Patients who have complications related to surgery e.g. cerebral insult with significant impact on cognitive functions after surgery

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

288 participants in 2 patient groups

Usual Care

No Intervention group

Description:

Today, no post-discharge telephone support is offered as standard care from the hospital.

Intervention group

Experimental group

Description:

Experimental group is offered 24/7-telephone support during the first 1 month post-discharge, and patients are actively called at day 2 and day 9 day after discharge.

Treatment:

Other: 24/7-telephone support